Screener
Gyre Therapeutics, Inc. GYRE Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | Gyre Pharmaceuticals | Gyre | Total |
|---|---|---|---|
| Revenues | $29,097 | $8 | $29,105 |
| Operating expenses | |||
| Cost of revenues | 2,209 | — | 2,209 |
| Selling and marketing | 13,754 | — | 13,754 |
| Research and development | 9,697 | 4,603 | 14,300 |
| Research and development - related parties | 4,836 | — | 4,836 |
| General and administrative | 4,268 | 3,594 | 7,862 |
| Transaction costs | — | 502 | 502 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s total revenue?
- Gyre Therapeutics, Inc. (GYRE) reported total revenue of $29.11M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s total revenue changed year-over-year?
- Gyre Therapeutics, Inc.'s total revenue decreased by 2.1% year-over-year, from $29.73M to $29.11M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s total revenue?
- Over 3 years (2021 to 2025), Gyre Therapeutics, Inc.'s total revenue has grown at a 153.5% compound annual growth rate (CAGR), from $7.34M to $119.55M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Gyre Therapeutics, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude